New Mexico Educational Retirement Board’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.32M Hold
19,700
0.08% 226
2026
Q1
$2.6M Hold
19,700
0.08% 248
2025
Q4
$2.79M Hold
19,700
0.08% 220
2025
Q3
$2.77M Hold
19,700
0.09% 213
2025
Q2
$2.48M Hold
19,700
0.08% 234
2025
Q1
$2.18M Hold
19,700
0.08% 255
2024
Q4
$2.69M Hold
19,700
0.09% 202
2024
Q3
$2.27M Hold
19,700
0.08% 257
2024
Q2
$2.71M Hold
19,700
0.09% 184
2024
Q1
$2.72M Hold
19,700
0.1% 186
2023
Q4
$2.6M Hold
19,700
0.1% 180
2023
Q3
$2.22M Hold
19,700
0.09% 188
2023
Q2
$1.86M Buy
19,700
+2,300
+13% +$225K 0.08% 240
2023
Q1
$1.76M Buy
17,400
+2,400
+16% +$250K 0.09% 220
2022
Q4
$1.79M Hold
15,000
0.1% 204
2022
Q3
$1.59M Hold
15,000
0.09% 226
2022
Q2
$1.46M Sell
15,000
-4,500
-23% -$415K 0.07% 268
2022
Q1
$1.83M Hold
19,500
0.07% 299
2021
Q4
$1.66M Hold
19,500
0.06% 379
2021
Q3
$1.87M Hold
19,500
0.07% 307
2021
Q2
$1.9M Buy
19,500
+2,800
+17% +$268K 0.07% 313
2021
Q1
$1.62M Buy
+16,700
New +$1.75M 0.06% 315

Other funds holding NBIX

New Mexico Educational Retirement Board's NBIX Position: Q2 2026 in Review

New Mexico Educational Retirement Board held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 19,700 shares worth $3.32M. The position accounts for 0.08% of the portfolio, ranked #226.

New Mexico Educational Retirement Board first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 260 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • New Mexico Educational Retirement Board held 19,700 shares of Neurocrine Biosciences worth $3.32M as of Q2 2026.
  • New Mexico Educational Retirement Board left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up 0.08% of New Mexico Educational Retirement Board's portfolio in Q2 2026, its #226 holding.
  • New Mexico Educational Retirement Board first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 260 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on New Mexico Educational Retirement Board's 13F filing for Q2 2026, filed 29 Jul 2026.